Nephrogenic diabetes insipidus

American Journal of Medicine

Volumn 105, Issue 5, 1998, Pages 431-442

  Eichet, Daniel G ^a  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN; ARGIPRESSIN; VASOPRESSIN;

AUTOSOMAL RECESSIVE INHERITANCE; DEHYDRATION; DRUG RECEPTOR BINDING; GENE MUTATION; HUMAN; KIDNEY DISEASE; NEPHROGENIC DIABETES INSIPIDUS; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; VASOPRESSIN RELEASE;

EID: 0032212881     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00301-5     Document Type: Article

References (79)

1. 1. Bichet DG. Posterior pituitary. In: Melmed S, ed. The Pituitary. Cambridge, MA: Blackwell Scientific Publications, 1995;277-306.
2. 2. Williams PD, Pettibone DJ. Recent advances in the development of oxytocin receptor antagonists. Curr Pharm Design. 1996;2:41-58.
3. 3. Kalogeras KT, Nieman LN, Friedman TC, et al. Inferior petrosal sinus sampling in healthy human subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion. J Clin Invest. 1996;97:2045-2050.
4. 4. Litwack G, Schmidt TJ. Biochemistry of hormones I: polypeptide hormones. In: Devlin TM, ed. Textbook of Biochemistry with Clinical Correlations. 4th ed. New York: Wiley-Liss, 1997;839-891.
5. 5. Morel A, O'Carroll A-M, Brownstein MJ, Lolait SJ. Molecular cloning and expression of a rat V1a arginine vasopressin receptor. Nature. 1992;356:523-526.
6. 6. Birnbaumer M, Seibold A, Gilbert S, et al. Molecular cloning of the receptor for human antidiuretic hormone. Nature. 1992;357:333-335.
7. 7. Lolait SJ, O'Carroll A-M, McBride OW, Konig M, Morel A, Brownstein MJ. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature. 1992; 357:336-339.
8. 8. Thibonnier M, Auzan C, Madhun Z, Wilkins P, Berti-Mattera L, Clauser E. Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor. J Biol Chem. 1994;269:3304-3310.
9. 9. Sugimoto T, Saito M, Mochizuki S, Watanabe Y, Hashimoto S, Kawashima H. Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem. 1994;269:27088-27092.
10. 10. de Keyzer Y, Auzan C, Lenne F, et al. Cloning and characterization ofthe human V3 pituitary vasopressin receptor. FEBS Letters. 1994; 356:215-220.
11. 11. Lolait SJ, O'Carroll A-M, Mahan LC, et al. Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc Natl Acad Sci. 1995;92:6783-6787.
12. 12. Rozen F, Russo C, Banville D, Zingg H. Structure, characterization, and expression of the rat oxytocin receptor gene. Proc Natl Acad Sci USA. 1995;92:200-204.
13. 13. Kimura T, Tanizawa O, Mori K, Brownstein MJ, Okayama H. Structure and expression of a human oxytocin receptor. Nature. 1992;356:526-529.
14. 14. Watson S, Arkinstall S. The G Protein Linked Receptor Factsbook. London: Academic Press, 1994.
15. 15. Ostrowski NL, Young WS II, Knepper MA, Lolait ST. Expression of vasopressin V1a and V2 receptor messenger ribonucleic acid in the liver and kidney of embryonic, developing, and adult rats. Endocrinol. 1993;133:1849-1859.
16. 16. Ostrowski NL, Lolait SJ, Young WS III. Cellular localization of vasopressin V1a receptor messenger ribonucleic acid in adult male rat brain, pineal, and brain vasculature. Endocrinol. 1994;135:1511-1528.
17. 17. Grazzini E, Lodboerer AM, Perez-Martin A, Joubert D, Guillon G. Molecular and functional characterization of V1b vasopressin receptor in rat adrenal medulla. Endocrinol. 1996;137:3906-3914.
18. 18. Walz T, Hirai T, Murata K, et al. The three-dimensional structure of aquaporin-1. Nature. 1997;387:624-627.
19. 19. Cheng A, van Hoek AN, Yeager M, Verkman AS, Mitra AK. Three-dimensional organization of a human water channel. Nature. 1997; 387:627-630.
20. 20. Agre P, Preston GM, Smith BL, et al. Aquaporin CHIP: the archetypal molecular water channel. Am J Physiol. 1993;34:F463-F476.
21. 21. Lee MD, King LS, Agre P. The aquaporin family of water channel proteins in clinical medicine. Medicine. 1997;76:141-156.
22. 22. Mouillac B, Chini B, Balestre M-N, et al. The binding site of neuropeptide vasopressin V1a receptor. J Biol Chem. 1995;270:25771-25777.
23. 23. Chini B, Mouillac B, Ala Y, et al. Tyr 115 is the key residue for determining agonist selectivity in the V1a vasopressin receptor. EMBO J. 1995;14:2176-2182.
24. 24. Serradeil-Le Gal C, Lacour C, Valette G, et al. Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist. J Clin Invest. 1996;98:2729-2738.
25. 25. Liu J, Wess J. Different single receptor domains determine the distinct G protein coupling profiles of members of the vasopressin receptor family. J Biol Chem. 1996;271:8772-8778.
26. 26. Seibold A, Brabet P, Rosenthal W, Birnbaumer M. Structure and chromosomal localization of the human antidiuretic hormone receptor gene. Am J Hum Genet. 1992;51:1078-1083.
27. 27. Nomura Y, Onigata K, Nagashima T, et al. Detection of skewed X-inactivation in two female carriers of vasopressin type 2 receptor gene mutation. J Clin Endocrinol Metab. 1997;82:3434-3437.
28. 28. Crawford ID, Bode HH. Disorders of the posterior pituitary in children. In: Gardner LI, ed. Endocrine and Genetic Diseases of Childhood and Adolescence. 2nd ed. Philadelphia: W.B. Saunders, 1975; 126-158.
29. 29. Forssman H. On the mode of hereditary transmission in diabetes insipidus. Nordisk Med. 1942;16:3211-3213.
30. 30. Waring AG, Kajdi L, Tappan V. Congenital defect of water metabolism. Am J Dis Child. 1945;69:323-325.
31. 31. Williams RM, Henry C. Nephrogenic diabetes insipidus transmitted by females and appearing during infancy in males. Ann Int Med. 1947;27:84-95.
32. 32. Niaudet P, Dechaux M, Trivin C, Loirat C, Broyer M. Nephrogenic diabetes insipidus: Clinical and pathophysiological aspects. Adv Nephrol Necker Hosp. 1984;13:247-260.
33. 33. McIlraith CH. Notes on some cases of diabetes insipidus with marked family and hereditary tendencies. Lancet. 1892;ii:767-768.
34. 34. Reeves WB, Andreoli TE. Nephrogenic diabetes insipidus. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The Metabolic Basis of Inherited Disease. 7th ed. New York McGraw-Hill, 1995;3045-3071.
35. 35. Lacombe UL. De la polydipsie [Thesis of Medicine, no. 99]. Imprimerie et Fonderie de Rignoux; 1841.
36. 36. Weil A. Ueber die hereditare form des diabetes insipidus. Archives fur Pathologische Anatomie und Physiologie and fur Klinische Medicine (Virchow's Archives). 1884;95:70-95.
37. 37. Weil A. Ueber die hereditare form des diabetes insipidus. Deutches Archiv fur Klinische Medizin. 1908;93:180-290.
38. 38. Camerer JW. Eine ergänzung des Weilschen diabetes-insipidusstammbaumes. Archiv für Rassen-und Gesellschaftshygiene Biologie. 1935;28:382.
39. 39. Dolle W. Eine weitere ergänzung des Weilschen diabetes-insipidusstammbaumes. Zeitschrift für Menschliche Vererbungs-und Konstitutionslehre. 1951;30:372-374.
40. 40. Rittig R, Robertson GL, Siggaard C, et al. Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus. Am J Hum Genet. 1996;58:107-117.
41. 41. Streitz JMJ, Streitz JM. Polyuric urinary tract dilatation with renal damage. J Urol. 1988;139:784-785.
42. 42. Boyd SD, Raz S, Ehrlich RM. Diabetes insipidus and nonobstructive dilatation of urinary tract. Urology. 1980;16:266-269.
43. 43. Gautier B, Thieblot P, Steg A. Mégauretère, mégavessie et diabète insipide familial. Sem Hop. 1981;57:60-61.
44. 44. Bichet DG, Razi M, Arthus M-F, et al. Epinephrine and dDAVP administration in patients with congenital nephrogenic diabetes insipidus. Evidence for a pre-cyclic AMP V2 receptor defective mechanism. Kidney Int. 1989;36:859-866.
45. 45. Bichet DG, Hendy GN, Lonergan M, et al. X-linked nephrogenic diabetes insipidus: From the ship Hopewell to restriction fragment length polymorphism studies. Am J Hum Genet. 1992;51:1089-1102.
46. 46. Kambouris M, Dlouhy SR, Trofatter JA, Conneally PM, Hodes ME. Localization of the gene for X-linked nephrogenic diabetes insipidus to Xq28. Am J Med Genet. 1988;29:239-246.
47. 47. Knoers N, van der Heyden H, van Oost BA, Monnens L, Willems J, Ropers HH. Three-point linkage analysis using multiple DNA polymorphic markers in families with X-linked nephrogenic diabetes insipidus. Genomics. 1989;4:434-437.
48. 48. van Den Ouweland AM, Knoop MT, Knoers W, et al. Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region. Genomics. 1992;13:1350-1352.
49. 49. Jans DA, van Oost BA, Ropers HH, Fahrenholz F. Derivatives of somatic cell hybrids which carry the human gene locus for nephrogenic diabetes insipidus (NDI) express functional vasopressin renal V2-type receptors. J Biol Chem. 1990;265:15379-15382.
50. 50. Bichet DG, Birnbaumer M, Lonergan M, et al. Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus. Am J Hum Genet. 1994;55:278-286.
51. 51. Cannon JF. Diabetes insipidus clinical and experimental studies with consideration of genetic relationships. Arch Intern Med. 1955; 96:215-272.
52. 52. Bichet DG, Arthus M-F, Lonergan M, et al. X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis. J Clin Invest. 1993;92:1262-1268.
53. 53. Bode HH, Crawford JD. Nephrogenic diabetes insipidus in North America: The Hopewell hypothesis. NEJM. 1969;280:750-754.
54. 54. Holtzman EJ, Kolakowski LF, O'Brien D, Crawford JD, Ausiello DA. A null mutation in the vasopressin V2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus in the Hopewell kindred. Hum Mol Genet. 1993;2:1201-1204.
55. 55. Vaithinathan R, Berson EL, Dryja TP. Further screening of the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa. Genomics. 1994;21:461-463.
56. 56. Ala Y, Morin D, Sabatier N, et al. Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol. 1998;9:1861-1872.
57. 57. Schöneberg T, Yun J, Wenkert D, Wess J. Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a coexpressed receptor polypeptide. EMBO J. 1996;15: 1283-1291.
58. 58. Schöneberg T, Sandig V, Wess J, Gudermann T, Schultz G. Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. J Clin Invest. 1997;100:1547-1556.
59. 59. Vargas-Poussou R, Forestier L, Dautzenberg MD, Niaudet P, Déchaud M, Antignac C. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol. 1997;8:1855-1862.
60. 60. Sadeghi H, Robertson GL, Bichet DG, Innamorati G, Birnbaumer M. Biochemical basis of partial NDI phenotypes. Mol Endocrinol. 1997;11:1806-1813.
61. 61. Deen PMT, Verdijk MAJ, Knoers NVAM, et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science. 1994;264:92-95.
62. 62. van Lieburg AF, Verdijk MAJ, Knoers NVAM, et al. Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet. 1994;55:648-652.
63. 63. Hochberg Z, van Lieburg A, Even L, et al. Autosomal recessive nephrogenic diabetes insipidus caused by an aquaporin-2 mutation. J Clin Endocrinol Metab. 1997;82:686-689.
64. 64. Mulders SB, Knoers NVAM, van Lieburg AF, et al. New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels. J Am Soc Nephrol. 1997; 8:242-248.
65. 65. Canfield MC, Tamarappoo BK, Moses AM, Verkman AS, Holtzman EJ. Identification and characterization of aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus with partial vasopressin response. Hum Mol Genet. 1997;6:1865-1871.
66. 66. Deen PMT, Croes H, van Aubel RAMH, Ginsel LA, van Os CH. Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest. 1995;95:2291-2296.
67. 67. Bichet DG, Razi M, Lonergan M, et al. Hemodynamic and coagulation responses to 1-desamino[8-D-arginine]vasopressin (dDAVP) infusion in patients with congenital nephrogenic diabetes insipidus. NEJM. 1988;318:881-887.
68. 68. van Lieburg AF, Knoers W, Mallmann R, Proesmans W, van den Heuvel LP, Monnens LA. Normal fibrinolytic responses to 1-desamino-8-D-arginine vasopressin in patients with nephrogenic diabetes insipidus caused by mutations in the aquaporin 2 gene. Nephron. 1996;72:544-546.
69. 69. Oksche A, Dickson J, Schülein R, et al. Two novel mutations in the vasopressin V2 receptor gene in patients with congenital nephrogenic diabetes insipidus. Biophys Biochem Res Com. 1994;205:552-557.
70. 70. van Lieburg AF, Verdijk MAJ, Schoute F, et al. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet. 1995;96:70-78.
71. 71. Bichet DG, Oksche A, Rosenthal W. Congenital nephrogenic diabetes insipidus. J Am Soc Nephrol. 1997;8:1951-1958.
72. 72. Marples D, Christensen S, Christensen EI, Ottosen PD, Nielsen S. Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest. 1995;95:1838-1845.
73. 73. Frokiaer J, Marples D, Knepper MA, Nielsen S. Bilateral ureteral obstruction downregulates expression of vasopressin-sensitive AQP-2 water channel in rat kidney. Am J Physiol. 1996;270 (suppl): F657-F668.
74. 74. Marples D, Frokiaer J, Dorup J, Knepper MA, Nielsen S. Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J Clin Invest. 1996;97: 1960-1968.
75. 75. Shayakul C, Knepper MA, Smith CP, DiGiovanni SR, Hediger MA. Segmental localization of urea transporter mRNAs in rat kidney. Am J Physiol. 1997;272(suppl):F654-F660.
76. 76. Bichet DG. Nephrogenic diabetes insipidus and vasopressin receptor. In: Spiegel AM, ed. Contemporary Endocrinology: G-Proteins, Receptors, and Diseases. Totowa, NJ: Humana Press, 1997;170-182.
77. 77. Sharif M, Hanley M. Stepping up the pressure. Nature. 1992;357: 279-280.
78. 78. Fushimi K, Sasaki S, Marumo F. Phosphorylation of serine 256 is required for cAMP-dependent regulatory exocytosis of the aquaporin-2 water channel. J Biol Chem. 1997;272:14800-14804.
79. 79. Katsura T, Gustafson C, Ausiello D, Brown D. Protein kinase A phosphorylation is involved in regulated exocytosis of aquaporin-2 intransfected LLC-PK1 cells. Am J Physiol. 1997;272(suppl):F817-F822.